Expert Commentary
View AllPublications
Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
The role of core strengthening for chronic low back pain.
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
Buckley DI, Calvert JF, Lapidus JA, et al.
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Garven A, Brady S, Wood S, Hatfield M, Bestard J, Korngut L, Toth C.
Pain Res Manag. 2011...
Pain Res Manag. 2011...
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
Barth KS, Becker WC, Wiedemer NL, Mavandadi S, Oslin DW, Meghani SH, Gallagher RM.
J Addict...
J Addict...
The role of core strengthening for chronic low back pain.
Akuthota V, Standaert CJ, Chimes GP.
PM R. 2011 Jul;3(7):664-70.
PM R. 2011 Jul;3(7):664-70.
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
Beck JG, Clapp JD.
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...







Treatment Agreements and Urine Drug Testing to Reduce Opioid Misuse in Patients with Chronic Pain
Joanna Starrels, MD, MS
Opioid misuse and the associated public health consequences have increased with the recent expansion of opioid prescribing for chronic pain. Various risk reduction strategies have been proposed to mitigate these risks, including opioid treatment agreements and urine drug testing. There is a dearth of evidence, however, on the effectiveness of these approaches. Starrels et al undertook a systematic review to synthesize existing evidence on the effects of treatment agreements and urine drug testing on opioid misuse outcomes—ie, drug abuse/misuse, aberrant drug-related behavior, diversion, addiction—in outpatients with chronic noncancer pain. Original studies with 50 participants or more were identified. Among 102 eligible studies, 11 met the inclusion criteria. All of these studies were observational and of poor to fair quality. A modest reduction in opioid misuse was observed in four studies following treatment agreements with or without urine drug testing. In the remaining studies, the results varied widely. Based on this review, it is evident that further research is needed on strategies to reduce opioid misuse.
References